{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:31:20Z","timestamp":1792679480086,"version":"4.5.0"},"reference-count":44,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0F8316N"],"award-info":[{"award-number":["G0F8316N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["T001018N"],"award-info":[{"award-number":["T001018N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2025,7,28]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Challenges in tuberculosis (TB) control have fuelled interest in routine next generation sequencing (NGS). However, the comparative performance of targeted NGS (tNGS) and whole genome sequencing (WGS) for drug resistance and genetic relatedness inference remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross-sectional study, we compared WGS (MICK-MAGMA platform) and the Deeplex MycTB tNGS assay in 90 patients with rifampicin-resistant TB in South Africa. A pairwise analysis was conducted for a total of 60 isolates, for which tNGS was conducted directly on DNA from sputum, and WGS on cultured isolates from the same samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Drug resistance inference was highly concordant (\u226592%) for most drugs, but lower for isoniazid (82%) and ethionamide (78%). Mixed infections were more commonly detected in tNGS (6.7%) than WGS (1.7%), though likely due to analytical errors. tNGS detected more minor variants (allelic frequency &lt;25%) than WGS (76\n                      <jats:italic>versus<\/jats:italic>\n                      32), with minimal overlap. Most minor variants were of unknown significance; some likely stemmed from contamination or sequencing errors. Heteroresistance involving minor variants was rare (4.7% in tNGS, 0% in WGS). WGS provided lineage and sublineage information for all samples, while tNGS reported lineage for 67% and sublineage for 20%. WGS classified more samples as genetically unrelated (76%) than tNGS (40%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this cohort, drug resistance inference was largely concordant between tNGS and WGS. WGS offered higher resolution for genetic relatedness, while tNGS showed greater sensitivity for minor variants. Further research is needed to clarify the clinical relevance of minor variants and assess the utility of WGS for transmission control.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/23120541.00630-2025","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:55:15Z","timestamp":1757609715000},"page":"00630-2025","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeted and whole-genome sequencing for drug resistance and genetic relatedness inference of rifampicin-resistant\n                    <i>Mycobacterium tuberculosis<\/i>\n                    : an in-depth comparison"],"prefix":"10.1183","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1909-7397","authenticated-orcid":false,"given":"Miguel","family":"de Diego Fuertes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilyn","family":"Costa Concei\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Rennie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6237-3898","authenticated-orcid":false,"given":"Tim","family":"Heupink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Churchyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7499-7486","authenticated-orcid":false,"given":"Felix","family":"Ndebele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"Van der Spoel Van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boitumelo","family":"Fanampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome","family":"Charalombous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Ayodeji Ogunbayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Quispe Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob M.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7666-3263","authenticated-orcid":false,"given":"Annelies","family":"Van Rie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anzaan","family":"Dippenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"2026022301500678000_12.1.00630-2025.1","unstructured":"World Health Organization . WHO Consolidated Guidelines on Tuberculosis. Module 3: Diagnosis. Geneva, World Health Organization, 2025."},{"key":"2026022301500678000_12.1.00630-2025.2","unstructured":"World Health Organization . WHO Consolidated Guidelines on Tuberculosis. Module 4 \u2013 Treatment: drug-resistant tuberculosis treatment. Geneva, World Health Organization, 2025."},{"key":"2026022301500678000_12.1.00630-2025.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1815121"},{"key":"2026022301500678000_12.1.00630-2025.4","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw502"},{"key":"2026022301500678000_12.1.00630-2025.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1505196"},{"key":"2026022301500678000_12.1.00630-2025.6","doi-asserted-by":"crossref","first-page":"e972","DOI":"10.1016\/S2666-5247(23)00172-6","article-title":"Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study","volume":"4","author":"Derendinger","year":"2023","journal-title":"Lancet Microbe"},{"key":"2026022301500678000_12.1.00630-2025.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00498-X"},{"key":"2026022301500678000_12.1.00630-2025.8","unstructured":"World Health Organization . Use of Xpert MTB\/RIF and Xpert MTB\/RIF Ultra on GeneXpert 10-Colour Instruments: WHO Policy Statement. Geneva, World Health Organization, 2021."},{"key":"2026022301500678000_12.1.00630-2025.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-019-0214-5"},{"key":"2026022301500678000_12.1.00630-2025.10","doi-asserted-by":"crossref","first-page":"775030","DOI":"10.3389\/fmicb.2022.775030","article-title":"Application of next generation sequencing for diagnosis and clinical management of drug-resistant tuberculosis: updates on recent developments in the field","volume":"13","author":"Dookie","year":"2022","journal-title":"Front Microbiol"},{"key":"2026022301500678000_12.1.00630-2025.11","unstructured":"World Health Organization . Use of Targeted Next-Generation Sequencing to Detect Drug-Resistant Tuberculosis. Geneva, World Health Organization, 2023."},{"key":"2026022301500678000_12.1.00630-2025.12","unstructured":"World Health Organization . The Use of Next-Generation Sequencing Technologies for the Detection of Mutations Associated with Drug Resistance in Mycobacterium tuberculosis Complex: Technical Guide. Geneva, World Health Organization, 2018."},{"key":"2026022301500678000_12.1.00630-2025.13","unstructured":"World Health Organization . Catalogue of Mutations in Mycobacterium tuberculosis Complex and their Association with Drug Resistance. WHO, World Health Organization, 2023."},{"key":"2026022301500678000_12.1.00630-2025.14","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1016\/S2666-5247(21)00301-3","article-title":"The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis","volume":"3","author":"Walker","year":"2022","journal-title":"Lancet Microbe"},{"key":"2026022301500678000_12.1.00630-2025.15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1011648"},{"key":"2026022301500678000_12.1.00630-2025.16","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.5895"},{"key":"2026022301500678000_12.1.00630-2025.17","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02338-2020"},{"key":"2026022301500678000_12.1.00630-2025.18","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01796-2020"},{"key":"2026022301500678000_12.1.00630-2025.19","unstructured":"Westhead J , Baker CS , Brouard M, et al. Enhancement and validation of the antibiotic resistance prediction performance of a cloud-based genetics processing platform for Mycobacteria. bioRxiv 2024; preprint [10.1101\/2024.11.08.622466]."},{"key":"2026022301500678000_12.1.00630-2025.20","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0279644"},{"key":"2026022301500678000_12.1.00630-2025.21","unstructured":"World Health Organization . Laboratory Biosafety Manual. 4th Edn. Geneva, World Health Organization, 2020."},{"key":"2026022301500678000_12.1.00630-2025.22","doi-asserted-by":"crossref","unstructured":"Schuerger C , Abdulla S , Puglisi A . Mapping Biosafety Level-3 Laboratories by Publications. Georgetown, Center for Security and Emerging Technology (CSET), 2022.","DOI":"10.51593\/20220019"},{"key":"2026022301500678000_12.1.00630-2025.23","doi-asserted-by":"crossref","first-page":"ofae320","DOI":"10.1093\/ofid\/ofae320","article-title":"Culture-free Whole Genome Sequencing for Mycobacterium tuberculosis using ligand-mediated bead enrichment method","volume":"11","author":"Vasanthaiah","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026022301500678000_12.1.00630-2025.24","unstructured":"Morgan GSK , Di Marco F, Moghaddasi K, et al. Whole Genome Sequencing analysis of M. tuberculosis from direct specimens: a hybrid capture approach. In European Society of Mycobacteriology Annual Congress, 23\u201326 June 2024, Bruges, Belgium."},{"key":"2026022301500678000_12.1.00630-2025.25","doi-asserted-by":"crossref","first-page":"1204064","DOI":"10.3389\/fpubh.2023.1204064","article-title":"Implementation of targeted Next-Generation Sequencing for the diagnosis of drug-resistant tuberculosis in low-resource settings: a programmatic model, challenges and initial outcomes","volume":"11","author":"de Araujo","year":"2023","journal-title":"Front Public Health"},{"key":"2026022301500678000_12.1.00630-2025.26","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1186\/s13063-022-06793-w","article-title":"sequencing mycobacteria and algorithm-determined resistant tuberculosis treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial","volume":"23","author":"Van Rie","year":"2022","journal-title":"Trials"},{"key":"2026022301500678000_12.1.00630-2025.27","doi-asserted-by":"publisher","DOI":"10.1099\/00207713-47-4-1236"},{"key":"2026022301500678000_12.1.00630-2025.28","doi-asserted-by":"crossref","unstructured":"Poplin R , Ruano-Rubio V , DePristo MA , et al. Scaling accurate genetic variant discovery to tens of thousands of samples. bioRxiv 2017; preprint [https:\/\/doi.org\/10.1101\/201178].","DOI":"10.1101\/201178"},{"key":"2026022301500678000_12.1.00630-2025.29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks918"},{"key":"2026022301500678000_12.1.00630-2025.30","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts378"},{"key":"2026022301500678000_12.1.00630-2025.31","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-015-1860-2"},{"key":"2026022301500678000_12.1.00630-2025.32","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0650-x"},{"key":"2026022301500678000_12.1.00630-2025.33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5812"},{"key":"2026022301500678000_12.1.00630-2025.34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16626-6"},{"key":"2026022301500678000_12.1.00630-2025.35","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msaa015"},{"key":"2026022301500678000_12.1.00630-2025.36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1473-3099(24)00586-3","article-title":"Evaluating culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis: a multicentre clinical study of two end-to-end commercial workflows","volume":"25","author":"Colman","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2026022301500678000_12.1.00630-2025.37","doi-asserted-by":"crossref","first-page":"11624","DOI":"10.1016\/j.diagmicrobio.2024.116249","article-title":"Concordance of targeted and whole genome sequencing for Mycobacterium tuberculosis genotypic drug susceptibility testing","volume":"109","author":"Cloutier Charette","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026022301500678000_12.1.00630-2025.38","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01164-21"},{"key":"2026022301500678000_12.1.00630-2025.39","doi-asserted-by":"publisher","DOI":"10.4102\/safp.v62i1.5026"},{"key":"2026022301500678000_12.1.00630-2025.40","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0660-8"},{"key":"2026022301500678000_12.1.00630-2025.41","doi-asserted-by":"crossref","first-page":"e0007024","DOI":"10.1128\/spectrum.00070-24","article-title":"Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid","volume":"12","author":"Rupasinghe","year":"2024","journal-title":"Microbiol Spectr"},{"key":"2026022301500678000_12.1.00630-2025.42","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1038\/s41467-024-51266-0","article-title":"Genetic diversity within diagnostic sputum samples is mirrored in the culture of Mycobacterium tuberculosis across different settings","volume":"15","author":"Mariner-Llicer","year":"2024","journal-title":"Nat Commun"},{"key":"2026022301500678000_12.1.00630-2025.43","doi-asserted-by":"crossref","first-page":"e1002961","DOI":"10.1371\/journal.pmed.1002961","article-title":"High-resolution mapping of tuberculosis transmission: whole genome sequencing and phylogenetic modelling of a cohort from Valencia Region, Spain","volume":"16","author":"Xu","year":"2019","journal-title":"PLoS Med"},{"key":"2026022301500678000_12.1.00630-2025.44","unstructured":"World Health Organization . WHO Operational Handbook on tuberculosis \u2013 Module 3: Diagnosis \u2013 Rapid Diagnostics for Tuberculosis Detection, in Web Annex C. Technical manual for culture-based drug susceptibility testing of anti-tuberculosis drugs used in the treatment of tuberculosis. Geneva, World Health Organization, 2024."}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00630-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T09:50:20Z","timestamp":1771840220000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00630-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2,23]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1183\/23120541.00630-2025"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00630-2025","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}